Clinical Trials Logo

Wounds and Injuries clinical trials

View clinical trials related to Wounds and Injuries.

Filter by:

NCT ID: NCT03303378 Recruiting - Clinical trials for Reperfusion Injury, Myocardial

Effects of Melatonin on Reperfusion Injury

Start date: November 1, 2017
Phase: N/A
Study type: Interventional

Acute myocardial infarction is a major cause of mortality and morbidity. Primary percutaneous coronary intervention (pPCI) is currently the most effective treatment strategy in acute myocardial infarction. However, a sizable number of patients fail to restore optimal myocardial reperfusion, mostly because of the 'no-reflow' phenomenon. Melatonin is the chief indoleamine produced by the pineal gland, and a well-known antioxidant and free radical scavenger. Several studies have shown that melatonin protects against ischemia/reperfusion injury (IRI). In our previous study, melatonin markedly reduced infarcted area, improved cardiac function and reduced lactate dehydrogenase release in rats. The investigators planned to research the cardioprotective effects of intravenous melatonin administered prior to reperfusion and continued after restoration of coronary blood flow in patients with ST segment elevation myocardial infarction undergoing pPCI.

NCT ID: NCT03302624 Recruiting - Quality of Life Clinical Trials

Follow-up of Long-term Renal Function After Acute Kidney Injury in ICU

SURIA
Start date: September 1, 2017
Phase: N/A
Study type: Observational

Acute kidney injury (AKI) involves poor prognosis in ICU patients. The renal prognosis at long term is unknown. The study will determine chronic kidney injury incidence and quality of life, five years after AK during ICU stay.

NCT ID: NCT03294863 Recruiting - Clinical trials for Linear Cutaneous Wound

Effectiveness of Embrace Scar Therapy Device After Cutaneous Wound Closure

Start date: March 15, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether the use of the embrace device after repair of linear cutaneous surgery wounds improves scar cosmesis.

NCT ID: NCT03290690 Recruiting - Wound Clinical Trials

Positive Predictive Value (PPV) of Pseudomonas Aeruginosa

Start date: August 4, 2017
Phase:
Study type: Observational

This is a non-randomized, single-blind post market clinical follow-up study for which 65 patients will be imaged at Rouge Valley Centenary Hospital (Scarborough and Rouge Hospital) who present with a chronic wound and are receiving standard wound care treatment. The MolecuLight i:X imaging device will be used by the study clinician as an adjunctive tool in the assessment of the wound and will be used to guide the targeted sampling of a wound (with curettage scraping), as per current standard of care in the principal investigator's wound care clinic. The acquired tissue sample will then be analysed using conventional gold standard semi-quantitative culture methods to determine bacterial species present, also as per current standard of care in this clinic.

NCT ID: NCT03284983 Recruiting - Surgery Clinical Trials

Split Scar Study to Assess Cosmetic Outcome From Differing Suture Spacing

SFD
Start date: July 1, 2017
Phase: N/A
Study type: Interventional

The investigators wish to determine how suture spacing (5 mm vs. 10 mm) affects cosmetic outcome and development of "train tracking" in wounds. Linear wounds with sutures spaced closer together may not be as cosmetically appealing when compared to those that have larger spacing between sutures. Suturing closer together constricts blood flow and increases tension that ultimately results in more tissue necrosis and a less appealing outcome. The investigators also aim to conclude if 5 mm or 10 mm suture spacing results in less complications.

NCT ID: NCT03281759 Recruiting - Clinical trials for Traumatic Brain Injury

Transcranial LED Therapy for Severe Acute Traumatic Brain Injury

LED-TBI
Start date: October 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate early and delayed effects of Transcranial LED Therapy (TCLT) and determinate whether this therapy is effective for cognitive rehabilitation of Diffuse Axonal Injury patients after Traumatic Brain Injury.

NCT ID: NCT03273062 Recruiting - Brain Injuries Clinical Trials

A Trial Evaluating Effects of COMT Inhibition in Patients With Acquired Brain Injury

Start date: July 20, 2017
Phase: Phase 2
Study type: Interventional

This is a follow-up study for an ongoing open label trial conducted by the Sheppard Pratt-Lieber Research Institute utilizing the catechol-O-methyl-transferase (COMT) inhibitor Tolcapone to evaluate its effects on cognition and neuropsychiatric symptoms in patients with brain injuries (BI). In this study, investigators will conduct a double-blind, placebo-controlled clinical trial utilizing a crossover design to study the effects of two weeks of Tolcapone 200mg administered three times a day (total of 600mg/day) on cognitive performance. Physical, emotional, cognitive and social functioning will also be evaluated through participant and proxy report. The investigators are planning to randomize a total of 12 patients with a history of acquired brain injury (BI).

NCT ID: NCT03271411 Recruiting - Clinical trials for Trauma, Psychological

Extension of EMDR vs. PC For Motor Vehicle Accident Trauma

Start date: August 30, 2017
Phase: N/A
Study type: Interventional

This is an extension of a randomized clinical trial comparing eye movement desensitization and reprocessing (EMDR) to progressive counting (PC) for volunteers from the community who are distressed by the memory of a motor vehicle accident. The purpose of this extension is to add Phil Manfield's recently developed Flash technique as a precursor to both EMDR and PC, to see a) if that has any impact on participant retention, treatment effectiveness, or treatment efficiency; and b) if such impact is equivalent with EMDR and PC.

NCT ID: NCT03271346 Recruiting - Clinical trials for Trauma, Psychological

Intensive Trauma Treatment for Children Exposed to Parental Conflict

Start date: February 2015
Phase: N/A
Study type: Observational

The purpose of this study is to track outcomes of the investigator's therapy approach with children of separation/divorce who have been exposed to parental conflict.

NCT ID: NCT03263325 Recruiting - Acute Kidney Injury Clinical Trials

Evaluation of UDP-glucose as a Urinary Biomarker for Early Detection of Cardiac Surgery-associated Pediatric Acute Kidney Injury

Start date: October 25, 2017
Phase:
Study type: Observational

Acute kidney injury (AKI) is common in children after cardiac surgery with a reported incidence of 20-40%. Pediatric AKI has been found to be associated with important short and long-term adverse outcomes. A major challenge to management of AKI after cardiac surgery and cardiopulmonary bypass is the lack of early diagnostic markers. Current diagnostic criteria for AKI in children relies exclusively on elevation of serum creatinine concentration and oliguria. Both of these markers lack sensitivity and specificity, and result in delayed detection of kidney injury. This study aims to determine if UDP-glucose can be used as a urinary biomarker to detect subclinical acute kidney injury following pediatric cardiac surgery with cardiopulmonary bypass.